Home/Filings/4/0001720081-17-000007
4//SEC Filing

Diaz Luis 4

Accession 0001720081-17-000007

CIK 0001640455other

Filed

Oct 22, 8:00 PM ET

Accepted

Oct 23, 8:29 AM ET

Size

5.2 KB

Accession

0001720081-17-000007

Insider Transaction Report

Form 4
Period: 2017-10-20
Diaz Luis
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-10-20+27,10027,100 total
    Exercise: $14.78Exp: 2027-10-20Common Stock (27,100 underlying)
Footnotes (1)
  • [F1]This option was granted on October 20, 2017 and will vest in equal quarterly installments during the twelve quarters following the grant date.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001720081

Filing Metadata

Form type
4
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 8:29 AM ET
Size
5.2 KB